Sagility is trading at ₹43.56, down 4.03%; available reports do not identify a clear company-specific explanation.
- On October 22, Sagility reported Q2 FY27 revenue growth of 22.6% and net profit growth of 13.1%, and announced its Chirok Health acquisition; sources do not connect either development to the decline.
- Available market reports show conflicting October 23 price action, so they do not reliably confirm the move or establish a broader-market cause.